Major Rating Factors:
Weak overall results on stability tests (1.1 on a scale of 0 to 10) including excessive premium growth and weak results on operational trends. The largest net exposure for one risk is excessive at 19.4% of capital. Fair long-term capitalization index (4.5) based on fair current risk adjusted capital (severe loss scenario), although results have slipped from the good range over the last two years.
Other Rating Factors:
Fair reserve development (3.6) as reserves have generally been sufficient to cover claims. Good liquidity (6.4) with sufficient resources (cash flows and marketable investments) to handle a spike in claims. Excellent profitability (8.6) despite modest operating losses during 2020.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
G - Fast asset or premium growth.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (98.5%), other (1.5%)
Licensed in:
CT, MA, MO, NH, NJ, NY
Principal Investments:
Investment grade bonds (66.8%), cash (7.8%), non investment grade bonds (6.4%), other (19.0%)
Corporate Info
Group Affiliation
China Minsheng Investment Co Ltd
Investment Rating
--
Company Address
1800 Northern Boulevard
Roslyn, NY 11576
Roslyn, NY 11576
Phone Number
(414) 369-5033
NAIC Number
21350
Website
Largest Affiliates
